Focusing on Treatment
Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX: VRX) completed its acquisition of Salix Pharmaceuticals, Ltd. ("Salix") on April 1, 2015.
Read the latest Investor Relations information from Valeant
About Us |
Healthcare Professional Resources |
Patient Resources |
News & Media |
Contact Us |